Abstract
To assess the effectiveness and safety of vildagliptin/metformin initial combination therapy in drug-naïve patients with type 2 diabetes mellitus (T2DM). INITIAL was a 24-week prospective, observational study in T2DM patients with glycated hemoglobin (HbA1c) ≥ 7.5%, and prescribed vildagliptin/metformin as initial combination therapy. The primary endpoint was change in HbA1c from baseline to week 24. Key secondary endpoints were HbA1c change from baseline to week 12, proportion of patients achieving HbA1c ≤7.0%, change in body weight at 12 and 24 weeks, change in HbA1c by sub-groups (baseline HbA1c, age, body mass index [BMI], dosage strength, co-morbidities) from baseline to week 24, and safety. A total of 532 patients were enrolled. The mean age, HbA1c, and BMI were 49.6 ± 11.27 years, 9.3 ± 1.57%, and 26.7 ± 4.50 kg/m2, respectively. Cardiovascular risk factors present at baseline were dyslipidemia (30.1%), hypertension (29.7%), and obesity (20.9%). The mean reductions in HbA1c from baseline to week 12 (-1.6 ± 1.59%) and 24 (-1.9 ± 1.70%) were statistically significant (p < .001). At 24 weeks, 39.6% of patients achieved HbA1c ≤ 7.0%, and the mean body weight reduction was -1.1 ± 2.62 kg. HbA1c reductions were consistently se...Continue Reading
References
Jan 18, 2007·JAMA : the Journal of the American Medical Association·Prashant JoshiSalim Yusuf
May 19, 2007·Diabetic Medicine : a Journal of the British Diabetic Association·A SchweizerS Dejager
Sep 12, 2008·The New England Journal of Medicine·Rury R HolmanH Andrew W Neil
Mar 27, 2009·Diabetes, Obesity & Metabolism·E BosiM Goodman
Oct 31, 2009·Lancet·Ambady RamachandranChamukuttan Snehalatha
Oct 30, 2010·Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [and] German Diabetes Association·N P E KadoglouN Sailer
Jan 14, 2011·The American Journal of Medicine·Bernard Zinman
Oct 1, 2011·Clinical Endocrinology·Soo LimHak Chul Jang
Mar 1, 2012·Diabetes, Obesity & Metabolism·C PanUNKNOWN Institution Investigators
Feb 19, 2013·Diabetes Care·Sarah Stark CasagrandeCatherine C Cowie
Jan 10, 2014·Diabetes, Obesity & Metabolism·R E PratleyC Wilson
Jan 10, 2014·Diabetes & Metabolism Journal·Young Ki LeeHyun Chul Lee
Mar 14, 2014·The Lancet. Diabetes & Endocrinology·Fiona Mitchell
Dec 30, 2014·Diabetes Care·Silvio E InzucchiDavid R Matthews
Jan 8, 2015·Vascular Health and Risk Management·Peter P Toth
Jan 15, 2015·Diabetes, Obesity & Metabolism·R RosalesZ A Latif
Jun 13, 2015·PloS One·Eu Jeong KuBo Ahrén
Oct 6, 2015·Endocrinology and Metabolism·Eun Jung Rhee
Feb 24, 2016·Indian Journal of Endocrinology and Metabolism·Bhavana SosaleSai Kandula
Jul 8, 2016·SpringerPlus·Tatsuya Watanabe, Mamoru Narukawa
Jul 28, 2016·Journal of Diabetes·Zachary Bloomgarden
Jan 18, 2017·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Alan J GarberGuillermo E Umpierrez
Mar 18, 2017·Current Medical Research and Opinion·Salah Shelbaya, Sameh Rakha